Your browser doesn't support javascript.
Excess all-cause mortality during COVID-19 outbreak: potential role of untreated cardiovascular disease.
Saglietto, Andrea; D'Ascenzo, Fabrizio; Cavarretta, Elena; Frati, Giacomo; Anselmino, Matteo; Versaci, Francesco; Biondi-Zoccai, Giuseppe; DE Ferrari, Gaetano M.
  • Saglietto A; Division of Cardiology, Department of Medical Sciences, Città della Salute e della Scienza, University of Turin, Turin, Italy - andrea.saglietto@live.com.
  • D'Ascenzo F; Division of Cardiology, Department of Medical Sciences, Città della Salute e della Scienza, University of Turin, Turin, Italy.
  • Cavarretta E; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, Rome, Italy.
  • Frati G; Mediterranea Cardiocentro, Naples, Italy.
  • Anselmino M; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, Rome, Italy.
  • Versaci F; IRCCS NEUROMED, Pozzilli, Isernia, Italy.
  • Biondi-Zoccai G; Division of Cardiology, Department of Medical Sciences, Città della Salute e della Scienza, University of Turin, Turin, Italy.
  • DE Ferrari GM; Unit of Hemodynamics and Cardiology, Santa Maria Goretti Hospital, Latina, Italy.
Minerva Cardiol Angiol ; 70(2): 160-166, 2022 04.
Article in English | MEDLINE | ID: covidwho-1786557
ABSTRACT

BACKGROUND:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has rapidly spread globally. Due to different testing strategies, under-detection of positive subjects and COVID-19-related-deaths remains common. Aim of this analysis was to assess the real impact of COVID-19 through the analysis of 2020 Italian all-cause mortality data compared to historical series.

METHODS:

We performed a retrospective analysis of 2020 and 2015-2019 all-cause mortality data released by the Italian National Institute for Statistics (ISTAT) for the time period January 1st-March 21st. This preliminary sample included 1084 Italian municipalities showing at least 10 deaths during the above-mentioned timeframe and an increase in mortality of more than 20% as compared to the previous five years (2015-2019), with a resulting coverage of 21% of Italian population. The difference between 2020 observed and expected deaths (mean of weekly deaths in 2015-2019) was computed, together with mortality rate ratio (MRR) for each of the four weeks following detection of the first autochthonous COVID-19 case in Italy (February 23rd, 2020 - March 21st, 2020), as well as for this entire timeframe. Subgroup analysis by age groups was also performed.

RESULTS:

Overall MRR was 1.79 [1.75-1.84], with an observed excess mortality of 8750 individuals in the investigated sample, which in itself outweighs Italian Civil Protection report of only 4,825 COVID-19-related deaths across Italy, as of March 21. Subgroup analysis did not show any difference in mortality rate in '0-14 years' age group, while MRRs were significantly increased in older age groups, in particular in patients >75 years (MRR 1.84 [1.79-1.89]). In addition, week-by-week analysis showed a progressive increase in MRR during this period, peaking in the last week (March 15th, 2020 - March 21st, 2020) with an estimated value of 2.65 [2.53-2.78].

CONCLUSIONS:

The analysis of all-cause mortality data in Italy indicates that reported COVID-19-related deaths are an underestimate of the actual death toll. All-cause death should be seen as the epidemiological indicator of choice to assess the real mortality impact exerted by SARS-CoV-2, given that it also best reflects the toll on frail patient subsets (e.g. the elderly or those with cardiovascular disease).
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Diseases / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Limits: Aged / Humans Language: English Journal: Minerva Cardiol Angiol Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Diseases / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Limits: Aged / Humans Language: English Journal: Minerva Cardiol Angiol Year: 2022 Document Type: Article